Varicella zoster-associated acute retinal necrosis and central nervous system complications in natalizumab treated MS patients
- 9 February 2021
- journal article
- letter
- Published by Elsevier BV in Multiple Sclerosis and Related Disorders
- Vol. 50, 102838
- https://doi.org/10.1016/j.msard.2021.102838
Abstract
No abstract availableKeywords
Funding Information
- Biogen
- Teva Pharmaceutical Industries
- Sanofi
- Genzyme
- Bayer
- EMD Serono
- Novartis
- Celgene
- Merck
- Roche
This publication has 13 references indexed in Scilit:
- VZV-associated acute retinal necrosis in a patient with MS treated with natalizumabNeurology Neuroimmunology & Neuroinflammation, 2018
- Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumabMultiple Sclerosis Journal, 2017
- Extratemporal herpes encephalitis during natalizumab treatment: A case reportMultiple Sclerosis and Related Disorders, 2016
- Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumabNeurology, 2016
- Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumabJournal of Neuroinflammation, 2014
- Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumabNeurology, 2013
- Central Nervous System Herpes Simplex and Varicella Zoster Virus Infections in Natalizumab-Treated PatientsClinical Infectious Diseases, 2013
- Acute retinal necrosis in the United Kingdom: results of a prospective surveillance studyEye, 2012
- Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UKBritish Journal of Ophthalmology, 2007
- The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virusJournal of the Neurological Sciences, 1998